Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Unknown 3Recruiting 3Not yet recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Thoracic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Carcinoma, Hepatocellular 4Recurrence 3Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Colorectal Neoplasms 3Burkitt Lymphoma 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Prolymphocytic, B-Cell 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Leukemia, B-Cell 2Glioma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor 1Simpson-Golabi-Behmel syndrome 1Sarcoma, Synovial 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1

Interventions

Cyclophosphamide 18fludarabine 7Rituximab 7Etoposide 7Cytarabine 7Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Filgrastim 5Cyclosporine 4Cisplatin 4fludarabine phosphate 3epratuzumab 3Vincristine 3Prednisone 3Methylprednisolone 3Indium 3Immunotherapy, Adoptive 3Doxorubicin 3Dexamethasone 3Busulfan 3Antilymphocyte Serum 3sargramostim 2Radioimmunodetection 2Paclitaxel 2Mycophenolic Acid 2Methotrexate 2Lym-1 monoclonal antibody 2Ifosfamide 2Hydrocortisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Burkitt Lymphoma × Immunotherapy, Adoptive × Clear all
NCT03467256 2023-02-24

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 1/2 Unknown
18 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04534634 2020-09-01

Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)

The First Affiliated Hospital of Soochow University

Phase 2 Unknown
60 enrolled
Lymphoid

Burkitt Lymphoma

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Shenzhen BinDeBio Ltd.

Phase 1/2 Unknown
73 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡